These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 10867871)

  • 1. [The role of modified low-density lipoproteins in physiology and pathology].
    Caialo PP; Pliushch HI
    Fiziol Zh (1994); 2000; 46(2):124-36. PubMed ID: 10867871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Processes of modification of lipoproteins. Physiological and pathogenetical role of modified lipoproteins].
    Belova LA; Ogloblina OG; Belov AA; Kukharchuk VV
    Vopr Med Khim; 2000; 46(1):8-21. PubMed ID: 10802881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modified low density lipoproteins in the pathogenesis of atherosclerosis.
    Laurman W
    Int J Occup Med Environ Health; 1994; 7(1):65-76. PubMed ID: 7921905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of anomalies of low density lipoproteins (LDL) in atherogenicity].
    Chapman JM; Guérin M; Bruckert E
    Bull Acad Natl Med; 2001; 185(1):35-7; discussion 38-9. PubMed ID: 11474567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pomegranate juice flavonoids inhibit low-density lipoprotein oxidation and cardiovascular diseases: studies in atherosclerotic mice and in humans.
    Aviram M; Dornfeld L; Kaplan M; Coleman R; Gaitini D; Nitecki S; Hofman A; Rosenblat M; Volkova N; Presser D; Attias J; Hayek T; Fuhrman B
    Drugs Exp Clin Res; 2002; 28(2-3):49-62. PubMed ID: 12224378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of C-reactive protein with low-density lipoproteins: implications for an active role of modified C-reactive protein in atherosclerosis.
    Ji SR; Wu Y; Potempa LA; Qiu Q; Zhao J
    Int J Biochem Cell Biol; 2006; 38(4):648-61. PubMed ID: 16376133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-density lipoprotein oxidation.
    Iuliano L; Micheletta F; Violi F
    Ital Heart J; 2001 Dec; 2(12):867-72. PubMed ID: 11838329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling the interaction of peroxynitrite with low-density lipoproteins. III: the role of antioxidants.
    Stanbro WD
    J Theor Biol; 2000 Aug; 205(3):473-82. PubMed ID: 10882566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of low-density lipoprotein in the pathogenesis of atherosclerosis].
    Zák A; Rublicová J; Skorepa J
    Cas Lek Cesk; 1978 Oct; 117(42):1305-10. PubMed ID: 214233
    [No Abstract]   [Full Text] [Related]  

  • 10. [A comparative study of the lipid phase in native and circulating multiple-modified low-density lipoproteins of human blood by the use of the spin probe method].
    Vakhrusheva TV; Panasenko OM; Mel'nichenko AA; Orekhov AN
    Biofizika; 2005; 50(4):652-9. PubMed ID: 16212056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipids and atherosclerosis.
    Choy PC; Siow YL; Mymin D; O K
    Biochem Cell Biol; 2004 Feb; 82(1):212-24. PubMed ID: 15052339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of microscopy in understanding atherosclerotic lysosomal lipid metabolism.
    Jerome WG; Yancey PG
    Microsc Microanal; 2003 Feb; 9(1):54-67. PubMed ID: 12597787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling the interaction of peroxynitrite with low-density lipoproteins. II: reaction/diffusion model of peroxynitrite in low-density lipoprotein particles.
    Stanbro WD
    J Theor Biol; 2000 Aug; 205(3):465-71. PubMed ID: 10882565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling the interaction of peroxynitrite with low-density lipoproteins. I. Plasma levels of peroxynitrite.
    Stanbro WD
    J Theor Biol; 2000 Aug; 205(3):457-64. PubMed ID: 10882564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypochlorous acid and human blood low density lipoproteins modified by hypochlorous acid increase erythrocyte adhesion to endothelial cells.
    Gorbatenkova EA; Artmann GM; Panasenko OM
    Membr Cell Biol; 2000; 13(4):537-46. PubMed ID: 10926371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of modified oxidation of low density lipoprotein in pathognesis of atherosclerosis].
    Siennicka A; Zapolska-Downar D
    Postepy Hig Med Dosw; 2003; 57(2):219-37. PubMed ID: 12866357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased levels of high-density lipoprotein cholesterol are ineffective in inhibiting the development of immune responses to oxidized low-density lipoprotein and atherosclerosis in transgenic rabbits expressing human apolipoprotein (apo) A-I with severe hypercholesterolaemia.
    Boullier A; Hennuyer N; Tailleux A; Furman C; Duverger N; Caillaud JM; Castro G; Fievet C; Fruchart JC; Duriez P
    Clin Sci (Lond); 2001 Mar; 100(3):343-55. PubMed ID: 11222122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A critical overview of the chemistry of copper-dependent low density lipoprotein oxidation: roles of lipid hydroperoxides, alpha-tocopherol, thiols, and ceruloplasmin.
    Burkitt MJ
    Arch Biochem Biophys; 2001 Oct; 394(1):117-35. PubMed ID: 11566034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide, peroxynitrite and lipoxygenase in atherogenesis: mechanistic insights.
    Rubbo H; O'Donnell V
    Toxicology; 2005 Mar; 208(2):305-17. PubMed ID: 15691594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidized low density lipoproteins: a role in the pathogenesis of atherosclerosis in diabetes?
    Lyons TJ
    Diabet Med; 1991 Jun; 8(5):411-9. PubMed ID: 1830524
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.